Report Summary

The global point of care (PoC) diagnostics market size is estimated to grow at a CAGR of 10.3% from 2018 to 2025. The Point of Care (PoC) diagnostics, are medical devices or tools that helps to diagnose the disease in patients’ community. The point of care diagnostics test kits are easy to handle and more accurate. The rising prevalence of lifestyle related diseases, increasing government support towards awareness about PoC testing kits, increasing venture capital activities and investments, technological advancements and new product launches, and rising number of regulatory approvals for novel immunoassay techniques are the key factors contributing towards the growth of global point of care diagnostics market.

The global point of care (PoC) diagnostics market is segmented by product type, mode of prescription, end user, and by region. On the basis of product type, the global Point of care (PoC) diagnostics market is further sub segmented into cardio metabolic monitoring kits, infectious disease testing kits, glucose monitoring kits, coagulation monitoring kits, pregnancy and fertility testing kits, tumor/cancer markers, urinalysis testing kits, hematology testing kits, cholesterol test strips, drugs-of-abuse testing kits, fecal occult testing kits, and other point of care testing kits. The cardio metabolic monitoring kits segment is further segmented into HBA1C testing kits, electrolytes testing kits/blood gas, cardiac markers, and LIPID testing kits. The glucose monitoring segment by product type is estimated to account major share in the global point of care diagnostics market. The rising prevalence of diabetes globally is the key factors influencing the growth of the point of care diagnostics market globally. The infectious disease testing kits segment is further sub segmented into HIV testing kits, influenza testing kits, hepatitis C testing kits, tropical diseases testing kits, sexually transmitted diseases (STDs) testing kits, respiratory infections testing kits, and others. The infectious disease segment by product type in the global point of care diagnostics market is estimated to grow at high pace during the forecast period. The increasing prevalence of infectious diseases such as HIV is expected to propel the growth of segment in the point of care diagnostics market globally. The fertility and pregnancy testing kits segment is further segmented into fertility testing kits, and pregnancy testing kits. The coagulation monitoring kits segment is further sub segmented into activated clotting time (ACT/APTT) testing kits, and PT/INR testing kits.

Point of Care (PoC) Diagnostics Market Scope

By Product Type By Mode of Prescription By End User By Region Cardio Metabolic Monitoring Kits

Infectious Disease Testing Kits

Glucose Monitoring Kits

Coagulation Monitoring Kits

Pregnancy & Fertility Testing Kits

Tumor/Cancer Markers

Urinalysis Testing Kits

Hematology Testing Kits

Cholesterol Test Strips

Drugs-Of-Abuse Testing Kits

Fecal Occult Testing Kits

Other Point Of Care Testing Kits OTC Testing Kits

Prescription Based Testing Kits Outpatient Healthcare Settings

Hospitals & Ambulatory Care Centers

Research Laboratories

Home Care Settings

Others North America (U.S., Canada)

Europe (Germany, UK, France, Italy, Spain, Belgium, Russia, Netherlands)

Asia-Pacific (China, Japan, India, Australia, Korea, Singapore, Malaysia, Indonesia, Thailand, Philippines)

Latin America (Brazil, Mexico, Argentina)

Middle East and Africa (UAE, Saudi Arabia, South Africa)

Segment Analysis

By mode of prescription, the global point of care diagnostics market is segmented into OTC testing kits, and prescription-based testing kits. The prescription-based testing kits segment by mode of prescription is estimated to account major share in the global point of care diagnostics market. The increasing prevalence and incidences of lifestyle related diseases is one of the major factors contributing towards the growth segment in the global point of care diagnostics market.

On the basis of end user, the global point of care (PoC) diagnostics market is further segmented into professional diagnostics centers, research laboratories home care settings, and others. The professional diagnostics segment by end user accounted major share in the global point of care diagnostics market. The professional diagnostics centers segment comprises outpatient healthcare settings, hospitals, and ambulatory care centers. The home care settings segment by end user is estimated to grow at high CAGR during the forecast period.

Regional Analysis

By geography, the global point of care (PoC) diagnostics market is segmented into five major regions, North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The North America is estimated to account major share in global Point of Care (PoC) Diagnostics market in 2017 and expected to remain dominant during the forecast period. The presence of top players of point of care diagnostics in the region, and high adoption of technically advanced testing kits are the key factor responsible for the growth of market in the region. The Asia Pacific is expected to grow at high CAGR in the during the forecast period owing to increasing awareness about Point of Care (PoC) Diagnostics, increasing infectious diseases, and growing research in the region is expected to propel the growth of region over the forecast period.

Competitive Landscape

The key players operating in global Point of Care (PoC) diagnostics market includes, Abbott Laboratories, Inc., Roche Diagnostics, Siemens AG, Beckman Coulter, Inc., Becton, Dickinson and Company, bioMerieux, Johnson & Johnson, Instrumentation Laboratory, PTS Diagnostics, and Nova Biomedical among others. The increasing investment in research and development activities across the top players is expected to propel the growth of market in the global point of care diagnostics market.